ArticleScientific reports2024

Differences in axillary response and treatment implications in HER2 positive node positive breast cancer during neoadjuvant HER2 targeted dual therapy.

Exian Mou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.